AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Rivaroxaban in South Africa
100 products registered with SAHPRA — 91 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| RIVAXORED 15 | 52/8.2/0180 | Dr ReddyÆs Laboratories (Pty) Ltd | active | 13 Mar 2030 |
| RIVAXORED 20 | 52/8.2/0181 | Dr ReddyÆs Laboratories (Pty) Ltd | active | 13 Mar 2030 |
| RIVAXORED 10 | 52/8.2/0179 | Dr ReddyÆs Laboratories (Pty) Ltd | active | 13 Mar 2030 |
| RIVAROXABAN 20 HETERO | 56/8.2/1104.1096 | Hetero Drugs South Africa (Pty) Ltd | active | 21 Jan 2030 |
| XARHET 10 | 56/8.2/1098.1094 | Hetero Drugs South Africa (Pty) Ltd | active | 21 Jan 2030 |
| RIVAROXABAN 2,5 HETERO | 56/8.2/1101.1093 | Hetero Drugs South Africa (Pty) Ltd | active | 21 Jan 2030 |
| XARHET 2,5 | 56/8.2/1097.1093 | Hetero Drugs South Africa (Pty) Ltd | active | 21 Jan 2030 |
| RIVAHET 20 | 56/8.2/1096 | Hetero Drugs South Africa (Pty) Ltd | active | 21 Jan 2030 |
| RIVAHET 15 | 56/8.2/1095 | Hetero Drugs South Africa (Pty) Ltd | active | 21 Jan 2030 |
| RIVAHET 10 | 56/8.2/1094 | Hetero Drugs South Africa (Pty) Ltd | active | 21 Jan 2030 |
| RIVAHET 2,5 | 56/8.2/1093 | Hetero Drugs South Africa (Pty) Ltd | active | 21 Jan 2030 |
| XARHET 20 | 56/8.2/1100.1096 | Hetero Drugs South Africa (Pty) Ltd | active | 21 Jan 2030 |
| RIVAROXABAN 10 HETERO | 56/8.2/1102.1094 | Hetero Drugs South Africa (Pty) Ltd | active | 21 Jan 2030 |
| XARHET 15 | 56/8.2/1099.1095 | Hetero Drugs South Africa (Pty) Ltd | active | 21 Jan 2030 |
| RIVAROXABAN 15 HETERO | 56/8.2/1103.1095 | Hetero Drugs South Africa (Pty) Ltd | active | 21 Jan 2030 |
| RIVAROXABAN 20 CIPLA | 56/8.2/0949 | Cipla Medpro (Pty) Ltd | active | 3 Dec 2029 |
| MEDPRALTO 2,5 | 56/8.2/0950.946 | Cipla Medpro (Pty) Ltd | active | 3 Dec 2029 |
| MEDPRALTO 20 | 56/8.2/0953.949 | Cipla Medpro (Pty) Ltd | active | 3 Dec 2029 |
| MEDPRALTO 15 | 56/8.2/0952.948 | Cipla Medpro (Pty) Ltd | active | 3 Dec 2029 |
| MEDPRALTO 10 | 56/8.2/0951.947 | Cipla Medpro (Pty) Ltd | active | 3 Dec 2029 |
| RIVAROXABAN 15 CIPLA | 56/8.2/0948 | Cipla Medpro (Pty) Ltd | active | 3 Dec 2029 |
| RIVAROXABAN 10 CIPLA | 56/8.2/0947 | Cipla Medpro (Pty) Ltd | active | 3 Dec 2029 |
| RIVAROXABAN 2,5 CIPLA | 56/8.2/0946 | Cipla Medpro (Pty) Ltd | active | 3 Dec 2029 |
| RIXARORA 20 | 56/8.2/0330 | Accord Healthcare (Pty) Ltd | active | 20 Aug 2029 |
| RIXARORA 10 | 56/8.2/0328 | Accord Healthcare (Pty) Ltd | active | 20 Aug 2029 |
| RIXARORA 15 | 56/8.2/329 | Accord Healthcare (Pty) Ltd | active | 20 Aug 2029 |
| RIXARORA 2,5 | 56/8.2/0327 | Accord Healthcare (Pty) Ltd | active | 4 Jun 2029 |
| RIVROMB 20 mg | 54/8.2/0666 | Pharmacare Limited û Woodmead | active | 27 Feb 2029 |
| RIVROMB 15 mg | 54/8.2/0665 | Pharmacare Limited û Woodmead | active | 27 Feb 2029 |
| RIVROMB 10 mg | 54/8.2/0664 | Pharmacare Limited û Woodmead | active | 27 Feb 2029 |
| CLIROXAR 20 | 56/8.2/0315 | Equity Pharmaceutical (Pty) Ltd | active | 23 Jan 2029 |
| XAVARE 15 | 56/8.2/0147 | Unicorn Pharmaceuticals (Pty) Ltd | active | 23 Jan 2029 |
| XAVARE 2,5 | 56/8.2/0145 | Unicorn Pharmaceuticals (Pty) Ltd | active | 23 Jan 2029 |
| XAVARE 10 | 56/8.2/0146 | Unicorn Pharmaceuticals (Pty) Ltd | active | 23 Jan 2029 |
| XAVARE 20 | 56/8.2/0148 | Unicorn Pharmaceuticals (Pty) Ltd | active | 23 Jan 2029 |
| CLIROXAR 15 | 56/8.2/0314 | Equity Pharmaceutical (Pty) Ltd | active | 23 Jan 2029 |
| CLIROXAR 10 | 56/8.2/0313 | Equity Pharmaceutical (Pty) Ltd | active | 23 Jan 2029 |
| KIXOREV 10 mg | 56/8.2/0744.741 | Macleods Pharmaceuticals SA (Pty) Ltd | active | 31 Oct 2028 |
| KIXOREV 20 mg | 56/8.2/0746.743 | Macleods Pharmaceuticals SA (Pty) Ltd | active | 31 Oct 2028 |
| KIXOREV 15 mg | 56/8.2/0745.742 | Macleods Pharmaceuticals SA (Pty) Ltd | active | 31 Oct 2028 |
| XABRIVA 20 mg | 56/8.2/0743 | Macleods Pharmaceuticals SA (Pty) Ltd | active | 31 Oct 2028 |
| XABRIVA 15 mg | 56/8.2/0742 | Macleods Pharmaceuticals SA (Pty) Ltd | active | 31 Oct 2028 |
| XABRIVA 10 mg | 56/8.2/0741 | Macleods Pharmaceuticals SA (Pty) Ltd | active | 31 Oct 2028 |
| MYOROXA 20 | 56/8.2/0553 | iPharma (Pty) Ltd | active | 3 Oct 2028 |
| MYOROXA 15 | 56/8.2/0552 | iPharma (Pty) Ltd | active | 3 Oct 2028 |
| MYOROXA 10 | 56/8.2/0551 | iPharma (Pty) Ltd | active | 3 Oct 2028 |
| XABANAR 20 mg | 56/8.2/0219 | Trinity Pharma (Pty) Ltd | unknown | 8 Aug 2028 |
| XABANAR 10 mg | 56/8.2/0217 | Trinity Pharma (Pty) Ltd | unknown | 8 Aug 2028 |
| XABANAR 15 mg | 56/8.2/0218 | Trinity Pharma (Pty) Ltd | unknown | 8 Aug 2028 |
| RABOVIX 20 mg | 55/8.2/0721.719 | Viatris South Africa (Pty) Ltd | active | 11 Jul 2028 |
| XAVIAT 15 mg | 55/8.2/0722.718 | Viatris South Africa (Pty) Ltd | active | 11 Jul 2028 |
| REXARAV 15 mg | 55/8.2/0718 | Viatris South Africa (Pty) Ltd | active | 11 Jul 2028 |
| REXARAV 20 mg | 55/8.2/0719 | Viatris South Africa (Pty) Ltd | active | 11 Jul 2028 |
| RABOVIX 15 mg | 55/8.2/0720.718 | Viatris South Africa (Pty) Ltd | active | 11 Jul 2028 |
| XAVIAT 20 mg | 55/8.2/0723.719 | Viatris South Africa (Pty) Ltd | active | 11 Jul 2028 |
| RUBAROX 15 | 55/8.2/0490 | Ruby Pharmaceuticals (Pty) Ltd | active | 18 Apr 2028 |
| RUBAROX 10 | 55/8.2/0489 | Ruby Pharmaceuticals (Pty) Ltd | active | 18 Apr 2028 |
| RUBAROX 20 | 55/8.2/0491 | Ruby Pharmaceuticals (Pty) Ltd | active | 18 Apr 2028 |
| AZIRIV 10 | 55/8.2/0492.489 | Ruby Pharmaceuticals (Pty) Ltd | active | 18 Apr 2028 |
| AZIRIV 15 | 55/8.2/0493.490 | Ruby Pharmaceuticals (Pty) Ltd | active | 18 Apr 2028 |
| AZIRIV 20 | 55/8.2/0494.491 | Ruby Pharmaceuticals (Pty) Ltd | active | 18 Apr 2028 |
| XAVIAT 10 mg | 55/8.2/0717.715 | Viatris South Africa (Pty) Ltd | active | 4 Apr 2028 |
| RABOVIX 10 mg | 55/8.2/0716.715 | Viatris South Africa (Pty) Ltd | active | 4 Apr 2028 |
| RIVAROXABAN 20 mg PD | 55/8.2/0145.142 | Pharma Dynamics (Pty) Ltd | active | 4 Apr 2028 |
| RIVAROXABAN 15 mg PD | 55/8.2/0144.141 | Pharma Dynamics (Pty) Ltd | active | 4 Apr 2028 |
| RIVAROXABAN 10 mg PD | 55/8.2/0143.140 | Pharma Dynamics (Pty) Ltd | active | 4 Apr 2028 |
| AXOLTA 20 mg | 55/8.2/0142 | Pharma Dynamics (Pty) Ltd | active | 4 Apr 2028 |
| AXOLTA 15 mg | 55/8.2/0141 | Pharma Dynamics (Pty) Ltd | active | 4 Apr 2028 |
| AXOLTA 10 mg | 55/8.2/0140 | Pharma Dynamics (Pty) Ltd | active | 4 Apr 2028 |
| REXARAV 10 mg | 55/8.2/0715 | Viatris South Africa (Pty) Ltd | active | 4 Apr 2028 |
| RIVAROXABAN TEVA 15 | 54/8.2/0418 | Teva Pharmaceuticals (Pty) Ltd | suspended | 9 Jul 2025 |
| RIVAROXABAN TEVA 10 | 54/8.2/0417 | Teva Pharmaceuticals (Pty) Ltd | suspended | 9 Jul 2025 |
| RIVAROXABAN TEVA 20 | 54/8.2/0419 | Teva Pharmaceuticals (Pty) Ltd | suspended | 9 Jul 2025 |
| RIVAROXABAN 10 mg SHANUR | 53/8.2/0200 | Shanur Healthcare (Pty) Ltd | active | 11 Mar 2025 |
| RIVAROXABAN 20 mg SHANUR | 53/8.2/0202 | Shanur Healthcare (Pty) Ltd | active | 11 Mar 2025 |
| RIVAROXABAN 15 mg SHANUR | 53/8.2/0201 | Shanur Healthcare (Pty) Ltd | active | 11 Mar 2025 |
| RAVELTO 10 | 55/8.2/0314.311 | Innovata Pharmaceuticals | suspended | 23 Dec 2024 |
| RAVELTO 15 | 55/8.2/0315.311 | Innovata Pharmaceuticals | suspended | 23 Dec 2024 |
| RAVELTO 20 | 55/8.2/0316.313 | Innovata Pharmaceuticals | suspended | 23 Dec 2024 |
| EMBIRIV 15 | 55/8.2/0318.312 | Ranbaxy (SA) (Pty) Ltd | active | 1 Jan 1900 |
| VAROXO 10 | 53/8.2/0272 | Adcock Ingram Limited | active | 1 Jan 1900 |
| RIVAROXABAN 15 ADCO | 53/8.2/0276.273 | Adcock Ingram Limited | active | 1 Jan 1900 |
| RIVAROXABAN 10 ADCO | 53/8.2/0275.272 | Adcock Ingram Limited | active | 1 Jan 1900 |
| XARELTO 10 | 42/8.2/1046 | Bayer (Pty) Ltd û Isando | active | 1 Jan 1900 |
| RIVAROXABAN 20 mg AUSTELL | 53/8.2/0199.196 | Austell Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| RIVAROXABAN 15 mg AUSTELL | 53/8.2/0198.195 | Austell Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| RIVAROXABAN 10 mg AUSTELL | 53/8.2/0197.194 | Austell Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| VAROXO 20 | 53/8.2/0274 | Adcock Ingram Limited | active | 1 Jan 1900 |
| VAROXO 15 | 53/8.2/0273 | Adcock Ingram Limited | active | 1 Jan 1900 |
| RIVAROXABAN 20 ADCO | 53/8.2/0277.274 | Adcock Ingram Limited | active | 1 Jan 1900 |
| RIVAR 10 | 55/8.2/0311 | Innovata Pharmaceuticals | active | 1 Jan 1900 |
| REZALTO 20 mg | 53/8.2/0196 | Austell Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| XARELTO 15 | 46/8.2/0111 | Bayer (Pty) Ltd û Isando | active | 1 Jan 1900 |
| RIVAR 20 | 55/8.2/0313 | Innovata Pharmaceuticals | active | 1 Jan 1900 |
| RIVAR 15 | 55/8.2/0312 | Innovata Pharmaceuticals | active | 1 Jan 1900 |
| EMBIRIV 20 | 55/8.2/0319.313 | Ranbaxy (SA) (Pty) Ltd | active | 1 Jan 1900 |
| EMBIRIV 10 | 55/8.2/0317.311 | Ranbaxy (SA) (Pty) Ltd | active | 1 Jan 1900 |
| REZALTO 15 mg | 53/8.2/0195 | Austell Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| REZALTO 10 mg | 53/8.2/0194 | Austell Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| XARELTO 20 | 46/8.2/0112 | Bayer (Pty) Ltd û Isando | active | 1 Jan 1900 |
Rivaroxaban — SAHPRA Registration Details
SAHPRA (South Africa) has 100 registered products containing Rivaroxaban, of which 91 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Rivaroxaban registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.